TELLUS THERAPEUTICS

tellus-therapeutics-logo

Tellus Therapeutics is developing novel small molecules derived from human maternal breast milk for the treatment of newborns with perinatal brain injury. It was founded in 2018 and is based in Hillsborough, North Carolina.

#SimilarOrganizations #People #Financial #Website #More

TELLUS THERAPEUTICS

Social Links:

Industry:
Biotechnology

Founded:
2018-01-01

Address:
Hillsborough, North Carolina, United States

Country:
United States

Website Url:
http://www.tellustherapeutics.com

Total Employee:
1+

Status:
Active

Contact:
919-491-4995

Total Funding:
53.5 M USD

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Google Font API Google Tag Manager WordPress Google Analytics Google Maps Font Awesome Global Site Tag


Similar Organizations

aardvark-therapeutics-logo

Aardvark Therapeutics

Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders.

aratana-therapeutics-logo

Aratana Therapeutics

Aratana Therapeutics develops innovative therapies for the animal health industry.

c4-therapeutics-logo

C4 Therapeutics

C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.

not_available_image

D2M Biotherapeutics

D2M Biotherapeutics focuses on the development of novel immunotherapeutics.

metis-therapeutics-logo

METiS Therapeutics

METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.


Current Advisors List

abid-ansari_image

Abid Ansari Financial Advisor @ Tellus Therapeutics
Advisor
2020-06-01

fred-callori_image

Fred Callori Board Member @ Tellus Therapeutics
Board_member
2022-12-01

chris-garabedian_image

Chris Garabedian Board Member @ Tellus Therapeutics
Board_member
2022-12-01

Current Employees Featured

jason-kralic_image

Jason Kralic
Jason Kralic Co-founder & CEO @ Tellus Therapeutics
Co-founder & CEO

Founder


jason-kralic_image

Jason Kralic

Investors List

xontogeny_image

Xontogeny

Xontogeny investment in Series A - Tellus Therapeutics

one-north-carolina-small-business-program_image

One North Carolina Small Business Program

One North Carolina Small Business Program investment in Grant - Tellus Therapeutics

xontogeny_image

Xontogeny

Xontogeny investment in Seed Round - Tellus Therapeutics

masschallenge_image

MassChallenge

MassChallenge investment in Non Equity Assistance - Tellus Therapeutics

north-carolina-biotechnology-center_image

North Carolina Biotechnology Center

North Carolina Biotechnology Center investment in Debt Financing - Tellus Therapeutics

masschallenge_image

MassChallenge

MassChallenge investment in Grant - Tellus Therapeutics

Official Site Inspections

http://www.tellustherapeutics.com

  • Host name: 149.113.180.107.host.secureserver.net
  • IP address: 107.180.113.149
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "Tellus Therapeutics"

About – Tellus Therapeutics

Jason Kralic, Ph.D., CEO and Co-founder Jason co-founded Tellus with Dr. Benner, and is a neuropharmacologist and life sciences business development executive with broad experience …See details»

Tellus Therapeutics

Tellus Therapeutics is a neonatal care company developing treatments for our most vulnerable patient populationSee details»

Tellus Therapeutics Company Profile 2024: Valuation, …

Information on valuation, funding, cap tables, investors, and executives for Tellus Therapeutics. Use the PitchBook Platform to explore the full profile.See details»

Tellus Therapeutics - Crunchbase Company Profile

TT-20: A small molecule derived from human maternal breast milk, currently in late-stage pre-clinical development, aimed at treating white matter injury …See details»

About OG – Tellus Therapeutics

Simon Gregory, Ph.D., Scientific Co-Founder and Scientific Advisory Board Member, is a Professor in the Department of Neurology, Duke University School of Medicine, and Research Director of the Duke Center for Research in …See details»

Tellus Therapeutics Executive Summary - National Institute of ...

Www.tellustherapeutics.com Dr. Jason Kralic PhD | jasonkralic@tellustherapeutics.com | 919-491-4995 | Durham, North Carolina | 2 employees Company Profile Tellus Therapeutics was …See details»

Tellus Therapeutics, Inc. Company Profile | Hillsborough, NC ...

Find company research, competitor information, contact details & financial data for Tellus Therapeutics, Inc. of Hillsborough, NC. Get the latest business insights from Dun & Bradstreet.See details»

Tellus Therapeutics Company Profile | Management and

Tellus Therapeutics Profile and History . As a preclinical stage life sciences start-up company, Tellus is focused on planning, funding and executing development programs to demonstrate …See details»

Tellus Therapeutics, Inc - LinkedIn

Tellus Therapeutics, Inc was thrilled to participate in the Alexandria Center® for Advanced Technologies (ACAT) Member Symposium. Our team, including Jason Kralic and Lilia Koza, …See details»

Tellus Therapeutics, Inc. - Drug pipelines, Patents, Clinical

Www.tellustherapeutics.com. Startups | Holding Company | 2018 | North Carolina, United States | < 10 | www.tellustherapeutics.com. Last update 01 Nov 2024. Overview. Pipeline. ... The …See details»

Tellus Therapeutics - Products, Competitors, Financials, Employees ...

Tellustherapeutics.com. Overview & Products; Financials; People; Founded Year 2018. Stage Series A | Alive. Total Raised $37.88M. Last Raised $35M | 2 yrs ago. About Tellus …See details»

Tellus Therapeutics - Overview, News & Similar companies

Dec 12, 2022 View Tellus Therapeutics (www.tellustherapeutics.com) location in North Carolina, United States , revenue, industry and description. Find related and similar companies as well …See details»

Tellus Therapeutics, Inc Information - RocketReach

Tellustherapeutics.com; 1 919684XXXX; View Similar People. Related Companies Total Exposure Designs. 10 $6m Flexcell International Corporation. 8 $5m TriClean, Inc. 9 $5.8m Beau …See details»

Tellus Therapeutics Inc. | North Carolina Biotech Center

Tellus Therapeutics is developing novel small molecules derived from human maternal breast milk for the treatment of newborns with perinatal brain and gut injuries.See details»

Tellus Therapeutics to develop first treatment for newborns with …

May 12, 2021 Tellus’ goal for its lead asset (TT-20) is to provide a treatment for every baby born at risk for brain injury and improve neurodevelopmental outcomes for affected children. For …See details»

Tellus Therapeutics - VentureRadar

Website: http://www.tellustherapeutics.com/ Develops interventions for newborns' unmet needs, utilizing compounds in breast milk to regenerate myelin and repair brain ...See details»

Tellus Therapeutics Inc Overview - Salary.com

Discover essential details about Tellus Therapeutics Inc, including address, contact, and journey of our company's evolution.See details»

Tellus Therapeutics Company Profile -Sales, Contacts, Competitors ...

Tellus Therapeutics is in the Pharmaceutical Preparations industry within the Chemicals and Allied Products sector and has been in business for approximately 6 years.See details»

R & D – Tellus Therapeutics

Neonatal white matter injury (WMI) is the leading cause of neurodevelopmental disability in survivors of preterm birth. Neurodevelopmental disability includes motor, cognitive and …See details»

Tellus Therapeutics Secures Seed Financing to Develop the First ...

May 12, 2021 jasonkralic@tellustherapeutics.com. Media: Katie Gallagher LaVoie Health Science kgallagher@lavoiehealthscience.com +1 617-792-3937. Katherine Marriott LaVoie …See details»

linkstock.net © 2022. All rights reserved